exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
Published 7 years ago • 296 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:41
dr. tolaney on activity with abemaciclib in patients with hr /her2– breast cancer
-
2:28
expert discusses promise of abemaciclib for breast cancer treatment
-
2:42
phase ii results for abemaciclib in pretreated hr /her2-negative breast cancer
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
3:15
brain metastases in her2 breast cancer
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
1:14
palbociclib shows promise for treatment of brain metastases harboring cdk alterations
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
7:09
abemaciclib for hr-positive metastatic breast cancer
-
2:00
a study of brain radiotherapy with lapatinib in her2 breast cancer
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
3:24
evolving treatment options in er metastatic breast cancer
-
5:02
brain metastases in her2-positive breast cancer